Navigation Links
$2 Million Awarded to Duke University Prevention Epicenter to Study Reduction of Healthcare-Associated Infections Using Tru-D, Total Room Ultraviolet Disinfection
Date:3/25/2011

DURHAM, N.C., March 25, 2011 /PRNewswire/ -- Centers for Disease Control and Prevention has awarded $2 million to Duke University Prevention Epicenter as part of its program to conduct innovative research in the science of preventing Healthcare-Associated Infections, or HAIs, with the goal of saving lives in healthcare settings. The Tru-D germicidal disinfection system was selected by Duke University after successful internal trials and published third-party data provided reliable, repeatable results. Five Tru-D instruments (Lumalier Corporation) will be deployed during the first two years of the grant.

CDC's Prevention Epicenters (PE) Program is a unique research program in which CDC's Division of Healthcare Quality Promotion (DHQP) collaborates with academic investigators to conduct innovative infection control and prevention research. CDC Director Thomas R. Frieden, M.D., M.P.H., stated, "With Prevention Epicenters, we can expand our current knowledge and save even more lives as we work toward our goal of eliminating HAIs." With the emergence of drug-resistant pathogens, strategies to reduce healthcare-associated infections are critical.

John Jernigan, M.D., M.S., director of CDC's Office of HAI Prevention Research and Evaluation, stated, "During the past decade, some of our biggest breakthroughs in healthcare infection prevention have been rooted in research of the Prevention Epicenter program, and we look forward to future advances." The Prevention Epicenter program helps uncover and implement solutions to help prevent infections, such as Tru-D Rapid Room Disinfection.

Published data indicate that Tru-D treatment eliminates environmental pathogens that cause MRSA, VRE, Acinetobactor, C. diff, and other acquired infections. Tru-D sensor technology uniquely "reads" the disinfection dynamics of each room to deliver a measured, lethal dose of germicidal energy within the room, including shadowed areas. Actual, real-time disinfection progress is displayed on a remote LCD screen.

"Epicenter funding is highly competitive. We selected Tru-D because its automated system is proven to significantly reduce environmental pathogens and eliminate human error in the disinfection process. The logical next step is to study the impact of a thoroughly disinfected patient environment in the prevention of HAIs," said Daniel Sexton, M.D., Medical Director of the Duke Infection Control Outreach Network (DICON).

The PE Program has resulted in over 150 publications in peer-reviewed journals on a variety of HAI prevention topics.

For additional information, please contact Jack Treas, CEO of Tru-D LLC, @ 800-774-5799, or visit online at http://www.Tru-D.net.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Lumalier Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AssureRx Health Raises $11 Million Series B Financing
2. AmeriCares Delivering $1.5 Million in Aid for Libya Crisis
3. Core Essence Secures $11.5 Million Series B Financing
4. Amgen Donates $1 Million to Help Japanese Disaster Victims
5. Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
6. Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions
7. BridgePoint Medical Closes $9.1 Million Series C Financing
8. Budget Solution? Modernizing Medicaid Pharmacy Could Save Florida $473 Million
9. FDA Approves BENLYSTA® for Lupus in Breakthrough for Millions of Sufferers
10. Six Health Plans Pay $1.5 Million in Incentives to Create Medical Homes for Nearly Half a Million Hudson Valley Residents
11. Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
(Date:5/10/2017)... May 10, 2017 Global Health Intelligence ... Latin America , published its 2017 ranking of the ... based on extensive data analysis from GHI,s hospitals database ... database for the region. The GHI database covers 86% of ... more than 130 data points for each institution in key ...
(Date:5/9/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... announced it has earned a spot on Forbes, ... Company was ranked among 500 U.S. employers as well ... Equipment and Services. The annual Forbes ... independent survey of over 30,000 employees across 25 industries. ...
Breaking Medicine Technology:
(Date:5/21/2017)... (PRWEB) , ... May 21, 2017 , ... ... if it's been longer than six months since you've seen a dentist, it's ... twice per year and getting x-rays once per year. , Dental checkups are ...
(Date:5/19/2017)... ... May 19, 2017 , ... When Kyle Busch graduates from ... will already appear on two major research studies that could impact the health of ... Matt Daggett, KCU alumnus and an orthopedic surgeon, alongside an international team trying to ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Arnold ... Young Investigators: , Victor Acosta, Ph.D. - University of New Mexico, Jeremy Baskin, ... - University of Washington, Erik Grumstrup, Ph.D. - Montana Stata University, A. Fatih ...
(Date:5/19/2017)... ... 2017 , ... CloSYS products which are marketed as the gentle giants of ... and gum health, which is linked to one’s overall health. Since 1991 when the ... powerful ways in which CloSYS products immediately helped eliminate bad breath as well as ...
(Date:5/18/2017)... ... ... Originally launched to market as the EPIK Learning Tab, the highly successful ... of their product line, the company believed it was the right time to create ... be any tablet product sold by EPIK Learning. This year there will be ...
Breaking Medicine News(10 mins):